Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial

Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial

Abstract Background For patients with a higher burden of localized prostate cancer, radiation dose escalation with brachytherapy boosts have improved cancer control outcomes at the cost of urinary toxicity. We hypothesize that a focal approach to brachytherapy boosts targeting only grossly visualize...

Full description

Bibliographic Details
Main Authors: C. Belliveau, M. Barkati, G. Delouya, D. Taussky, M. C. Beauchemin, C. Lambert, L. Beaulieu, D. Beliveau-Nadeau, B. Nicolas, J. F. Carrier, E. Vigneault, C. Ménard
Format: Article
Language:English
Published: BMC 2022-12-01
Series:Radiation Oncology
Subjects:
Prostate cancer
Stereotactic radiotherapy
Focal brachytherapy
Quality of life
Magnetic resonance imaging
Online Access:https://doi.org/10.1186/s13014-022-02173-5

Internet

https://doi.org/10.1186/s13014-022-02173-5

Similar Items